SEC Form 4 · accession 0001179110-15-000943
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Rothera
Officer — Chief Commercial Officer
Period of report
Jan 13, 2015
Accepted (ET)
Jan 15, 2015 · 7:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jan 13, 2015 | S | 3,000 | $56.51 | D | 6,000 | D | |
| Common Stock | Jan 13, 2015 | M | 5,500 | $10.85 | A | 11,500 | D | |
| Common StockF3 | Jan 13, 2015 | S | 5,500 | $58.75 | D | 6,000 | D | |
| Common Stock | Jan 14, 2015 | M | 1,200 | $10.85 | A | 7,200 | D | |
| Common StockF5 | Jan 14, 2015 | S | 1,200 | $58.62 | D | 6,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right To Buy)F4 | $10.85 | Jan 13, 2015 | M | 5,500 | A | — | May 15, 2023 | Common Stock | 5,500 | 141,500 | D |
| Stock Option (Right To Buy)F4 | $10.85 | Jan 14, 2015 | M | 1,200 | A | — | May 15, 2023 | Common Stock | 1,200 | 140,300 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan.
- F2This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $56.30 to $56.81 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $58.60 to $59.00 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F4This option was granted on May 15, 2013. 25% of the grant vested on May 15, 2014. The remainder vests as to 1/48 of the shares underlying such option each month until May 2017. One additional share was incorrectly reflected as exercised in the reporting person's Form 4 filed on September 26, 2014 and that error is corrected here.
- F5This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $58.60 to $58.72 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.